Stay updated on Durvalumab Combo in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.5.0 was added to the record history and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the version history.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedA new Study Status entry was added on 2026-02-10 and the version history shows 32 with Revision: v3.4.2. The page also removes a government funding operating status notice from the previous version.SummaryDifference0.8%

- Check47 days agoChange DetectedAdded a Notice about government funding lapse and the NIH facilities' operating status. Updated the page Revision from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check54 days agoChange DetectedAdded a 'Show glossary' option and explanatory text for color-coded differences (green for additions, red for deletions) along with the 'No FEAR Act Data' note, and updated the revision label from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check68 days agoChange DetectedRevision: v3.3.4 is now shown as the latest version, replacing v3.3.3. This change affects metadata only and does not alter trial records or displayed content.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Lung Cancer Clinical Trial page.